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Abstract
How cytokine-driven changes in chromatin topology are converted
into gene regulatory circuits during inflammation still remains
unclear. Here, we show that interleukin (IL)-1a induces acute and
widespread changes in chromatin accessibility via the TAK1 kinase
and NF-jB at regions that are highly enriched for inflammatory
disease-relevant SNPs. Two enhancers in the extended chemokine
locus on human chromosome 4 regulate the IL-1a-inducible IL8
and CXCL1-3 genes. Both enhancers engage in dynamic spatial
interactions with gene promoters in an IL-1a/TAK1-inducible
manner. Microdeletions of p65-binding sites in either of the two
enhancers impair NF-jB recruitment, suppress activation and bial-
lelic transcription of the IL8/CXCL2 genes, and reshuffle higher-
order chromatin interactions as judged by i4C interactome profiles.
Notably, these findings support a dominant role of the IL8
“master” enhancer in the regulation of sustained IL-1a signaling,
as well as for IL-8 and IL-6 secretion. CRISPR-guided transactiva-
tion of the IL8 locus or cross-TAD regulation by TNFa-responsive
enhancers in a different model locus supports the existence of
complex enhancer hierarchies in response to cytokine stimulation
that prime and orchestrate proinflammatory chromatin responses
downstream of NF-jB.
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Introduction
Inflammation is an evolutionarily conserved reaction to all forms of
tissue injury and a major cause of human disease (Wallach et al,
2014). The cytokines interleukin-1 (IL-1) and tumor necrosis factor-
alpha (TNFa) are potent mediators of inflammation across human
tissues (Rock et al, 2010). Upon binding to cognate cell-surface
receptors, IL-1 and TNFa initiate a cascade of cytosolic signaling
events to eventually exert control over specific transcription factors
(TFs) in the nucleus (Gaestel et al, 2009). A central upstream regula-
tor in this scenario is the TAK1 protein kinase that activates the IKK,
JNK, and p38 signaling pathways (Sakurai, 2012). All three path-
ways converge on regulating the nuclear concentration of TFs such
as NF-jB and AP-1, thereby mediating cytokine-driven transcription
at multiple responsive loci (Weber et al, 2010; Oeckinghaus et al,
2011; Zhang et al, 2017). While these modes of action are well estab-
lished, a major unresolved question concerns the contribution of the
non-coding genome to the coordinated IL-1/TNFa-triggered response
in the three-dimensional (3D) space of the cell nucleus—i.e., how
the various enhancers along chromosomes exert precise regulatory
1 Rudolf Buchheim Institute of Pharmacology, Justus Liebig University Giessen, Giessen, Germany
2 Center for Molecular Medicine Cologne, University of Cologne, Cologne, Germany
3 Department of Pathology, University Medical Center Göttingen, Göttingen, Germany
4 Research Core Unit Genomics, Institute of Physiological Chemistry, Medical School Hannover, Hannover, Germany
5 Institute for Genetics, Justus Liebig University Giessen, Giessen, Germany
6 Genomics Core Facility and Institute of Molecular Oncology, Philipps University Marburg, Marburg, Germany
7 Member of the German Center for Lung Research (DZL), Giessen, Germany
8 Center for Biomics, Erasmus Medical Center, Rotterdam, The Netherlands
9 Institute of Biochemistry, Justus Liebig University Giessen, Giessen, Germany
*Corresponding author. Tel: +49 551 65734; E-mail: argyris.papantonis@med.uni-goettingen.de
**Corresponding author. Tel: +49 641 9947600; E-mail: michael.kracht@pharma.med.uni-giessen.de
†These authors contributed equally to this work
ª 2019 The Authors. Published under the terms of the CC BY 4.0 license The EMBO Journal e101533 | 2019 1 of 22
effects of different magnitudes in 3D space and over time to their
cognate promoters during the inflammatory response.
Genomics approaches of increasing throughput now allow us to
probe thousands of putative cis-regulatory elements across
mammalian chromosomes (Long et al, 2016), also in response to
proinflammatory cues (Ghisletti et al, 2010; Ostuni & Natoli, 2013;
Kolovos et al, 2016). Genome-wide profiles for histone modifi-
cations, TF binding, and chromatin accessibility provide cell type-
specific catalogues of enhancers correlated with gene activation or
repression and with cell identity (Wang et al, 2008; Thurman
et al, 2012; Bowman & Poirier, 2015). However, assignment of the
activity and quantification of the strength of enhancers remains
challenging and requires perturbation strategies in their native
chromatin context (Nizovtseva et al, 2017; Furlong & Levine,
2018). In addition, enhancers operate under the spatial constraints
of interphase chromosomes, which are now understood to be
complex and often dynamic 3D entities. Mammalian chromosomes
harbor numerous topologically associating domains (TADs) that
mostly act to insulate enhancer function (Gibcus & Dekker, 2013;
Yu & Ren, 2017). This type of spatial organization directs long-
range regulatory interactions, and 3D chromatin topology can be a
critical factor in inflammation (Xu et al, 2017). Chromosome
conformation capture (3C) technology now allows mapping of
such spatial interactions (Dekker et al, 2013), although it is often-
times not possible to infer (dynamic) enhancer functions from the
mere presence of chromatin loops, chromatin modifications, or
open chromatin (Goldstein & Hager, 2018). Thus, the exact roles
of enhancers, especially those acting in an apparently concerted
manner on the same loci, remain poorly understood and need to
be studied on a case-by-case basis via loss- and gain-of-function
approaches to dissect their roles in the disease-relevant regulatory
networks mediating the inflammatory response (Snetkova & Skok,
2018; Vermunt et al, 2019).
We recently identified a large number of IL-1a/TAK1-regulated
enhancers in human epithelial cells characterized by inducible
H3K27ac and NF-jB demarcation (Jurida et al, 2015). Here, we
ask how different, yet concertedly activated, enhancers acting on
the same responsive genes exert their rapid and precise regulatory
function. We combine ATAC-seq, i4C-seq, and single-molecule
RNA FISH with CRISPR/Cas9 microdeletions of discrete NF-jB
binding elements or with CRISPR-guided transactivation to address
this question. In brief, we show that IL-1a stimulation induces
widespread remodeling of chromatin accessibility, in which the
role of NF-jB, hitherto considered secondary to that of priming
factors (Smale & Natoli, 2014), is both necessary and sufficient,
and even capable of ectopically decondensing heterochromatin.
Analysis of the prototypical CXCL chemokine locus on human
chromosome 4 revealed a hierarchical relationship between two
cytokine-induced enhancers. Remarkably, one of the enhancers
exerts dominant control over the whole locus via both pre-estab-
lished and dynamic contacts to gene promoters and other enhan-
cers. Ultimately, the IL8 enhancer controls secretion of the
abundant IL-8 and IL-6 factors, while also supporting sustained IL-
1a signaling to NF-jB and JNK/p38 MAP kinases. This suggests
that enhancer interplay can be more complex than currently appre-
ciated, involving a new type of “proinflammatory master enhan-
cers” to robustly produce rapid and quantitative differences in
gene expression.
Results
IL-1a stimulation drives widespread changes in chromatin
accessibility via TAK1 and NF-jB
IL-1a stimulation of human KB epithelial carcinoma cells leads to an
almost exclusive transcriptional induction of hundreds of genes
initiating the proinflammatory cascade. Previously, we showed that
induction is predominantly driven by NF-jB and that pharmacologi-
cal inhibition of the TAK1 kinase suppresses most of the response
(Jurida et al, 2015). To investigate dynamic changes of the chro-
matin landscape in response to IL-1a stimulation, we performed
ATAC-seq (Buenrostro et al, 2013) in resting and IL-1a-stimulated
KB cells in the presence or absence of the specific TAK1 inhibitor
5Z-7-oxozeaenol (TAKi). Widespread changes in accessibility along
responsive loci such as IL8 and TNFAIP3 were observed (Fig 1A),
but also genome-wide, with > 75,000 (76,687) ATAC-seq peaks
emerging specifically in response to IL-1a stimulation. Importantly,
accessibility at these IL-1a-induced peaks is abolished upon co-treat-
ment with the TAK1 inhibitor and, thus, dependent on TAK1-
mediated signaling (Fig 1B). Interestingly, > 50% (166,578) of all
ATAC-seq peaks recorded in IL-1a-stimulated cells were also already
accessible prior to cytokine induction, while ~15% (40,972) of these
peaks remain largely accessible despite TAKi co-treatment (Fig 1B).
Focusing on peaks that are rendered accessible in response to IL-1a,
we found that ~9% overlap H3K27ac marks. Compared to untreated
cells, these chromatin regions undergo remodeling to unmask NF-
jB and AP-1 (FOS/JUN) binding motifs with significant enrichments
(Fig 1C, left). Compared to TAKi- and IL-1a-co-treated cells, it was
essentially only the NFKB1/2 and RELB motifs of the NF-jB family
that showed diminished enrichment due to changes in local accessi-
bility. This suggests that the TAK1 pathway controls not only
nuclear translocation of TFs via inducible phosphorylation, but also
chromatin remodeling at a specific subset of NF-jB binding sites
(Fig 1C, right).
We then asked if these remodeled chromatin regions are related
to the proinflammatory gene expression program. We found 2,051
genes in the vicinity of the H3K27ac-marked ATAC-seq peaks
(within < 0.5 Mbp and in the same TAD), and these were highly
associated with gene ontology terms relevant to proinflammatory
responses (Fig 1D). Accordingly, accessibility at their TSSs was
induced by IL-1a and reduced upon TAKi treatment (Fig 1E). We
processed the ATAC-seq peaks assigned to these 2,051 genes via
GARLIC, a computational tool designed to statistically link disease-
relevant SNPs with putative cis-regulatory elements (Nikolic et al,
2017). This revealed significant association between SNPs in these
accessible sites and multiple common inflammatory diseases (e.g.,
rheumatoid arthritis, psoriasis, systemic lupus erythematosus, and
inflammatory bowel disease; Fig 1F). These results show that IL-
1a-/TAK1-derived signals exercise broad and genome-wide control
of disease-relevant non-coding elements.
Further independent evidence for a role of the TAK1-NF-jB path-
way in chromatin regulation was obtained using a heterologous
LacI-LacO reporter system (Jegou et al, 2009). The p65 subunit of
NF-jB, a key downstream effector of TAK1, proved sufficient to
open up chromatin locally in this assay (Appendix Fig S1A–C). The
observed decondensation of an otherwise heterochromatic region
was accompanied by concomitant reduction in H3K27me3 levels
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and accumulation of active histone marks (H3K36ac) and phospho-
rylated isoforms of RNA polymerase II (Appendix Fig S1D). In addi-
tion, TNFa induced an increase in chromatin accessibility, as
assessed at specific loci by formaldehyde-assisted isolation of regu-
latory elements (FAIRE), and this effect was suppressed by the
knockout of RELA (Appendix Fig S1E). Taken together, these data
define fundamental roles of factors (TAK1, p65) and cis-regulatory
elements (NF-jB, AP-1) in controlling cytokine-driven changes in
nucleosome density and chromatin accessibility in a concerted and
rapid manner.
IL-1a stimulation drives dynamic chromatin refolding in the
CXCL2 locus
We previously identified, by ChIP-seq in KB cells, four TAKi-sensi-
tive enhancer regions flanking the prototypical chemokine locus of
chromosome 4. They were characterized by IL-1-inducible
H3K27ac and p65 recruitment (as shown in Fig EV1 and in Jurida
et al, 2015), and we, therefore, used one of these enhancers down-
stream of the CXCL2 locus, as a viewpoint to ask whether IL-1a-
induced changes in chromatin accessibility also correlate with
changes in spatial configuration. We obtained native spatial inter-
actomes of the CXCL2 promoter and enhancer by applying the
“intrinsic (fixation-free) circularized chromosome conformation
capture” (i4C) approach (Brant et al, 2016). This revealed involve-
ment of the CXCL2 promoter in a number of pre-established
contacts with other IL-1a-inducible promoters and cis-regulatory
elements throughout its locus. IL-1a stimulation for 1 h led to
partial contact remodeling, mainly involving the responsive CXCL3,
CXCL1, and IL8 genes, as well as a number of enhancers and
CTCF-bound sites. Most of these contacts were abolished upon
TAKi treatment irrespective of IL-1a stimulation (Fig 2A, top),
showing the relevance of basal and constitutive TAK1 activity in
the process. The enhancer downstream of CXCL2 was found
looped to its cognate promoter already before IL-1a induction,
which then allows for NF-jB binding to this promoter (Jurida et al,
2015) and also leads to TAK1-dependent contacts with the CXCL1
and (less strongly) IL8 gene promoters (Fig 2A, bottom). Meta-
profiles of the average ATAC-seq and ChIP-seq signals at i4C
contacts of either the CXCL2 promoter or enhancer reveal that
accessibility and H3K27ac and NF-jB/RNA polymerase II binding
are generally increased by IL-1a stimulation and reduced by TAKi
(Fig 2B). Taken together, our data indicate that IL-1a-induced chro-
matin remodeling renders NF-jB sites accessible, is sensitive to
TAK1 inhibition, and allows rapid spatial redistribution of contacts
between IL-1a-responsive regulatory elements.
Identification of hierarchically organized enhancers controlling
the IL-1a response
To investigate the specific contribution of individual enhancers to
gene expression in the extended IL8/CXCL locus, we decided to
systematically delete those sites in the IL8 and CXCL2 proximal
enhancers that we previously showed to most strongly bind the NF-
jB p65 subunit in response to IL-1a treatment in KB and HeLa cells
(Jurida et al, 2015) (Fig EV1). As HeLa (in our hands) are much
more amenable to genetic perturbation, we used them to mutate
individual NF-jB sites within the enhancers directly upstream of IL8
or downstream of CXCL2 by CRISPR/Cas9-mediated homozygous
microdeletions of < 60 nt using pairs of sgRNAs (genomic positions
indicated in Fig EV1). The resulting lines were validated by Sanger
sequencing and are hereafter called Dp65eIL8 or Dp65eCXCL2 (Fig 3A).
However, before continuing with further experiments, we
decided to revisit some key features of the IL-1a-responsive chemo-
kine locus in both lines at the single-cell level. Both cell lines have
been used in the IL-1 field for decades (Saklatvala et al, 1991; Bird
et al, 1994; Freshney et al, 1994; Guesdon et al, 1997) and were
originally isolated as separate epithelial carcinoma cell lines (Eagle,
1955a,b), but KB cells were later found to be a derivative of HeLa
(Vaughan et al, 2017). While our HeLa and KB lines clearly differ
morphologically (Appendix Fig S2A), they both strongly activate the
chemokine cluster in response to IL-1a (as assessed by IL8 RNA
FISH) (Appendix Fig S2B and C). Compared to HeLa, KB cells show
a more uniform IL-1a response at the single-cell level (Appendix Fig
S2B and C). Moreover, DNA FISH reveals that KBs have two copies
of chr. 4 on average, while HeLa cells mainly possess four copies
(Appendix Fig S2D and E). Commercial short tandem repeat (STR)
profiling from isolated DNA confirmed that the KB and HeLa cells
used in this study are indeed identical in this aspect to original HeLa
(Appendix Fig S2F) (Dirks & Drexler, 2013). We conclude that KB
cells are a stable HeLa subclone that differs in copy number but
otherwise shows a prototypical IL-1a-mediated activation of the
CXCL chemokine locus.
In our enhancer-mutant HeLa lines, expression of all four chemo-
kine mRNAs encoded by the IL8/CXCL locus, as well as of typical
IL-1a-responsive genes on other chromosomes, was markedly
decreased along a 180-min time course (Fig 3B). These data show
that deletion of a single enhancer may affect not only the expression
◀ Figure 1. IL-1a-induced genome-wide changes in chromatin accessibility.A KB cells were treated for 30 min with the TAK1 inhibitor 5Z-7-oxozeaenol (TAKi, 1 lM). Then, half of the cells were stimulated with IL-1a for 60 min resembling
conditions previously described (Jurida et al, 2015). The cartoon illustrates the ATAC-seq experimental strategy (top). The genome browser views show representative
changes in chromatin accessibility in two prototypical IL-1a-responsive loci (IL8 and TNFAIP3).
B Venn diagrams illustrating shared and condition-specific ATAC-seq peak regions in KB cells treated with IL-1a in the presence or absence of the TAK1 inhibitor (TAKi).
Significant ATAC-seq peaks were determined using a more than twofold cutoff in read coverage over background together with a q-value of < 104.
C Analysis of TF motifs within ATAC-seq footprints in IL-1a-induced peaks overlapping H3K27ac (Pie chart) over those from uninduced (IL-1a) or TAKi-treated cells
(+IL-1a/+TAKi). Sequence logos and corrected discovery P-values for each motif are shown.
D Gene ontology (GO) terms associated with the 2,051 genes in the vicinity of H3K27ac marks to which ATAC-seq peaks forming upon IL-1a induction and being
sensitive to TAKi inhibition were assigned (Pie chart). Only genes within < 0.5 Mbp and the same TAD were included in this analysis.
E Average profiles of ATAC-seq signals in the 2 kbp around the 2,051 TSSs from panel (D).
F Diseases and traits associated with SNPs overlapping ATAC-seq footprints assigned to the 2,051 genes from panel (D); those with a known inflammatory component
are highlighted (red).
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of its cognate gene, but also the expression of all genes encoded in
its locus. Interestingly, the effects of the Dp65eCXCL2 deletion were
consistently less dramatic than those of the Dp65eIL8 one (e.g., for
CXCL1/3; Fig 3B). These enhancer-mutant lines, as well as a line
carrying both deletions (Dp65eIL8+eCXCL2), do not affect basal and IL-
1a-inducible mRNA stabilities of IL8 and CXCL2 mRNAs, thereby
ensuring that inhibition of gene activation manifests at the transcrip-
tional level (Fig EV2A). Microarray experiments in these three p65-
deletion lines revealed few changes at the whole-transcriptome level
(compared to vector controls; Figs 3C and EV2B–D, Table EV1), and
accordingly, there were also no changes in the 481 genes (out of 813
annotated genes) expressed from chr. 4 (Fig 3C). Together with the
preserved integrity and copy number of chr. 4 (as assessed by DNA
FISH in the Dp65eIL8 cell line; Appendix Fig S2D, E), our data indi-
cate that the microdeletions do not affect the overall structure of the
chromosome. Nonetheless, we recorded a profound suppression of
all major IL-1a-responsive genes (Figs 3C and EV2C). These are
almost exclusively related to the proinflammatory response
(Fig EV2D), and their suppression suggests a widespread effect of
these two single-enhancer microdeletions on the deployment of the
IL-1 transcriptional cascade.
To assess the impact of these enhancer microdeletions on chro-
matin modifications and NF-jB binding, we performed ChIP-qPCR
for histone marks, NF-jB (p65), and RNA polymerase II at the
promoters and enhancers of different IL-1a-responsive genes along a
180-min time course. Typically, p65 binding at the IL8 and CXCL2
promoters and enhancers will peak between 30 and 60 min post
stimulation. This was almost abolished in Dp65eIL8 cells, but in
Dp65eCXCL2, the IL8 promoter and enhancer did still detectably bind
p65 (Fig EV3A). Similarly, H3K27ac levels were strongly diminished
only in Dp65eIL8, while recruitment of initiating RNA polymerases
(phosphorylated at Ser5 of their CTDs) was significantly reduced
across the enhancer-mutant lines (Fig EV3A). Reduction of p65 and
RNA polymerase loading, as well as of H3K27ac, was seen for other
IL-1a-responsive genes in the same locus (CXCL1 and CXCL3), but
also for those on other chromosomes (IL6, CCL20, and NFKBIA).
This reveals an unforeseen impact by a single enhancer on many
inducible genes across the genome, in line with our microarray anal-
ysis. Again, this effect was more pronounced after deletion of the
IL8 rather than the CXCL2 enhancer, suggesting a hierarchal rela-
tionship between these two regulatory cis-elements (Fig EV3B).
The aforementioned widespread effect should ultimately affect
protein production—and in this case, the cells’ secretome. We
performed three types of analyses to assess the specificity and
magnitude of changes in enhancer-mutant cells at the protein level,
along an extended time course after IL-1 stimulation. First, we con-
firmed the sustained suppression of IL8 and IL6 mRNAs in the
Dp65eIL8 mutant cells compared to cells depleted for p65 by
CRISPR/Cas9 mutation of the RELA gene (Fig 3D, upper graphs).
Specific ELISAs performed on the supernatants of the same cell
cultures confirmed the suppression of secreted IL-8 and IL-6
proteins in the Dp65eIL8 mutant to an extent comparable to the RELA
knockout (Fig 3D, lower graphs). Second, profiling of 80 cytokines
by semi-quantitative antibody arrays showed that IL-6 and IL-8 are
indeed the most abundant IL-1a-induced secreted factors. This
approach also identified CCL20 (MIP-3a) as another factor that is
reduced in Dp65eIL8 cells similarly to RELA-knockout levels
(Appendix Fig S3; again in line with the RT–qPCR data in Fig 3B).
Third, the fact that we observed no difference in the overall secreted
proteome (assessed by silver staining of cell culture supernatants)
or in the newly synthesized secreted proteome (assessed by in vivo
puromycinylation of nascent peptide chains) between control cells
and the IL8 enhancer-mutant cells or p65-depleted cells (Fig 3E)
argues that the suppression of these inflammatory regulators was
strictly specific.
We next looked at the single-cell level and noted that nuclear
translocation of NF-jB is less efficient in the presence of individual
or combined enhancer deletions (Appendix Fig S4A, top row, and
Appendix Fig S4B), with the accumulation of the NF-jB-driven IL8
mRNA being strongly decreased 1 h post-stimulation and the
NFKBIA mRNA moderately suppressed (Appendix Fig S4A, middle/
bottom rows, and Appendix Fig S4C), again in line with our RT–
qPCR data (Fig 3B). In addition, at the level of the NF-jB signaling
cascade, its suppression in our enhancer-mutant lines is exemplified
by reduced IjBa phosphorylation and degradation, as well as by
reduced p65 phosphorylation in cell lysates (Appendix Fig S5A and
B). Despite p65 protein and mRNA levels remaining unchanged
(Appendix Fig S5A–C), more p65 was bound to IjBa protein in
Dp65eIL8 cells, thereby corroborating the inhibition of the cytosolic
NF-jB signaling (Appendix Fig S5D). Moreover, activation of JNK
and p38 MAPK was suppressed, revealing that these enhancers
control all three major IL-1a-triggered pathways (Appendix Fig S5A
and B), since the aforementioned IL-6, IL-8, and CCL20/MIP-3a (but
also CXCL2/GRO-ß/MIP-2a via CXCR2) are direct and indirect regu-
lators of canonical NF-jB and MAPK signaling (Heinrich et al, 2003;
Manna & Ramesh, 2005; Ha et al, 2017; Jin et al, 2018). Finally, this
enhancer-centric multilevel regulation is also supported by the
finding that deletion of the NF-jB binding site within the IL8
promoter (Dp65pIL8) only affected IL8 expression, but did not at all
impact other IL-1a target genes or the activation of NF-jB signaling
◀ Figure 2. The IL-1a–TAK1 pathway regulates spatial chromatin interactions by the CXCL2 locus.A Cross-linking-free chromosome conformation capture (i4C) analysis was performed using chromatin from KB cells  IL-1a stimulation for 60 min in the presence or
absence of a TAK inhibitor (TAKi). Shown are i4C profiles in the 1 Mbp around the CXCL2 locus on chromosome 4 (ideogram). Average read counts of two biological
replicates are plotted, generated using the CXCL2 promoter (blue highlight) or enhancer (pink highlight) as a viewpoint. The region of the IL8 promoter/enhancer is also
shown (gray highlight). Below each profile, significantly strong (brown), medium (red), or weaker interactions (orange) called via foursig software (Williams et al, 2014)
are indicated. All profiles are shown aligned to gene models (blue) and CTCF ChIP-seq, as well as to H3K27ac and H3K4me1 ChIP-seq data from KB cells
(GSE64224 + GSE52470) performed under the same conditions (Jurida et al, 2015). The breadth of topologically associating domains (TADs) in the locus is indicated
above.
B Meta-plots showing coverage of ATAC-seq (this study) and H3K27ac, p65, and RNA polymerase II (RNAPII) ChIP-seq signals (GSE64224 + GSE52470) at i4C
fragments  1 kbp contacted by the CXCL2 promoter or enhancer in KB cells  IL-1a stimulation for 60 min in the presence or absence of a TAK inhibitor (TAKi).
Source data are available online for this figure.
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(Fig EV4A–C). In contrast, RELA-knockout cells exhibit lower IjBa
levels and essentially no IL-1a responsiveness, thus providing a
control for the specificity of the other microdeletion phenotypes
(Fig EV4B and D).
Taken together, these observations suggest a presumably indirect
feedback mechanism that links the IL-1/IL-8 response to NF-jB
nuclear relocalization (and MAPK activation), providing an explana-
tion for the global effects of our enhancer mutants. Thus, HeLa lines
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carrying p65-binding site microdeletions reveal two hierarchically
organized enhancers controlling gene expression in the early-
responsive IL8/CXCL locus. While the IL8 “master” enhancer
displays a dominant effect on all genes in the locus, the CXCL2
enhancer seems to be subordinate and to not generate as strong an
effect. This suggests a unique hierarchy between distal enhancers
controlling timing and amplitude of gene expression across an entire
domain, but also in trans, in response to proinflammatory cues.
Enhancer-deletion mutants reveal a hierarchy in spatial
enhancer–promoter interactions
The dominant effect that the Dp65eIL8 deletion exerts on the regula-
tion of all IL-1a-inducible genes in its locus could be explained by
the spatial crosstalk among different promoters and enhancers. To
assess this, i4C experiments were performed in wild-type and
Dp65eIL8/Dp65eCXCL2 deletion cells using either the promoters or
enhancers of IL8 and CXCL2 as viewpoints, which reside within the
same TAD across cell types (Appendix Fig S6A). The IL8 promoter
is not found pre-looped to any other IL-1a-inducible promoter or
enhancer within its TAD, but 1 h of IL-1a stimulation resulted in
significant interactions with CXCL2 and putative enhancers (Fig 4A,
top). Using the IL8 enhancer as a viewpoint allowed the detection of
rapidly induced contacts between the IL8 and CXCL1 promoters
(Fig 4A, bottom). In the Dp65eIL8 line, interactions between the IL8
promoter and enhancer and CXCL2 are markedly diminished despite
IL-1a stimulation, whereas Dp65eCXCL2 cells still displayed rich inter-
actomes with CXCL1 and CXCL2 (Fig 4A). Overall, i4C contacts by
either the IL8 promoter or enhancer are more enriched for H3K27ac
than those in the Dp65eIL8/Dp65eCXCL2 cells (Fig 4B).
The CXCL2 promoter showed few interactions with other
genomic loci in unstimulated cells and developed strong contacts
with the CXCL1, CXCL3, and IL8 promoters after 1 h of IL-1a stim-
ulation (Appendix Fig S7A, top). The CXCL2 enhancer developed a
similar set of contacts to promoters post-stimulation, but also inter-
acted with the IL8 enhancer (Appendix Fig S7A, bottom). In
Dp65eCXCL2 cells, both the CXCL2 promoter and enhancer interac-
tomes are redirected away from IL-1a-inducible genes and regula-
tory elements (with the exception of the proximal CXCL3 gene;
Appendix Fig S7A). This is accentuated in i4C profiles of the
CXCL2 promoter in Dp65eIL8 cells, although the promoter and
enhancer of CXCL2 remained associated in all replicates analyzed.
Strikingly, the CXCL2 and IL8 enhancers studied here remain
spatially associated upon IL-1a stimulation regardless of the
genetic context of the cells tested (Appendix Fig S7A). Again, i4C
contacts by either the CXCL2 promoter or enhancer are on average
more enriched for H3K27ac than those in Dp65eIL8/Dp65eCXCL2 cells
(although less so than their IL8 counterparts; Appendix Fig S7B).
These data collectively reveal the importance of NF-jB-bound cis-
regulatory elements in rewiring chromatin interactions. To also
assess the contribution of the NF-jB p65 subunit in this cytokine-
regulated process, we analyzed RELA-knockout cells, which do not
show IL-1a-induced activation of CXCL2/IL8 (as shown in Figs 3D
and E, and EV4D and Appendix Fig S3C). Analysis of i4C interac-
tomes from DRELA HeLa showed spatial associations between the
IL8 promoter and CXCL2 promoter and enhancer, as well as with
CXCL3, indicating that NF-jB is likely not a main driver of looping
(Appendix Fig S8A).
In summary, all IL-1a-responsive promoters in the extended
chemokine locus can be found interacting with one another in dif-
ferent combinations, but strong interactions between the IL8 and
CXCL2 enhancers persist despite enhancer microdeletions or RELA
knockout. This direct crosstalk, in conjunction with the differential
i4C interactomes in the Dp65eIL8 and Dp65eCXCL2 lines, argues for a
dominant role of the IL8 “master” enhancer in the regulation of the
whole locus. Such a hierarchical dominance explains the observed
gene expression defects (Figs 3B–E and EV2C and D) on the basis of
rapid changes (or lack thereof) in chromatin conformation.
◀ Figure 3. Deletion of NF-jB binding elements from the IL8 and CXCL2 proximal enhancers in HeLa suppresses inducible mRNA expression and secretion ofIL-1a target genes.
A Genome browser views of the CXCL2 and IL8 chemokine loci on human chromosome 4 show H3K4me1, H3K4me3, H3K27ac, and RNA polymerase II ENCODE ChIP-seq
profiles from HeLa-S3 cells relative to the IL8 and CXCL2 gene models (blue). The locations of the deleted NF-jB binding sites in their flanking enhancer regions are
indicated (orange). Both loci were mutated using pairs of sgRNAs in stably transfected HeLa cell lines, and Sanger sequencing results of PCR-amplified genomic
regions using DNA of both enhancer-mutant cell lines (Dp65eIL8 and Dp65eCXCL2) confirmed removal of 56 and 59 bp, respectively. Blue shades mark the targeted
NF-jB binding sites.
B mRNA levels of seven IL-1a-responsive genes in control (empty vector) or enhancer-mutant (Dp65eIL8 and Dp65eCXCL2) HeLa lines was assessed by RT–qPCR (mean
levels  SEM, normalized to GUSB; n = 4 (vector, Dp65eIL8), n = 3 (Dp65eCXCL2)) at the indicated times after IL-1a stimulation. *: significantly different to control;
P < 0.01, unpaired, two-tailed Student’s t-test.
C Microarray gene expression analysis was performed in HeLa cells  IL-1a stimulation for 60 min on control (empty vector; n = 4) and three p65 enhancer-deletion
lines (Dp65eIL8, Dp65eCXCL2, and Dp65eIL8+eCXCL2; n = 2). Differentially expressed genes were identified based on a moderated t-test (P-value < 0.05) and at least
threefold change compared to the mean control levels (empty vector). The box plots show distribution of quantile-normalized mRNA expression values across all
experimental conditions and cell lines. Gene sets (from top to bottom) represent IL-1a-regulated genes, all significantly expressed genes, and all mRNAs expressed
from the genes of chromosome 4. Boundaries of the box indicate the 25th/75th percentiles, black lines within the box mark the medians, whiskers (error bars) indicate
the 10th/90th percentiles, and black dots mark the 5th/95th percentiles. Additional analyses are provided in Fig EV2B–D. The complete data are provided in Table EV1.
D Parental (wt), vector controls, IL8 enhancer-mutant cells (Dp65eIL8), or stable HeLa lines carrying CRISPR/Cas9-mediated mutations of the RELA gene (DRELA) and
therefore lacking p65 NF-jB (see also Fig EV4) were left untreated or stimulated with IL-1a as indicated. Then, total RNA from cell pellets and proteins from
supernatants were analyzed by RT–qPCR and ELISA, respectively. IL6 and IL8 mRNA levels are depicted relative to the unstimulated vector controls (upper panel). IL-8
and IL-6 cytokine levels were normalized to total RNA, and concentrations are shown (lower panels). Data are from three independent experiments; shown are
means  SD.
E Vector controls, IL8 enhancer-mutant cells (Dp65eIL8), or cells lacking p65 (DRELA) were left untreated or were stimulated with IL-1a for 8 h in serum-free cell culture
medium. After 7.5 h, half of the cells received puromycin for 30 min to label nascent polypeptides in vivo for monitoring ongoing translation (Iwasaki & Ingolia, 2017).
Then, supernatants were harvested and proteins were precipitated and analyzed for newly synthesized polypeptides by immunoblotting using anti-puromycin
antibodies (left panel) or for the entire stable secretome by silver staining (right panel). Shown is one out of two experiments yielding identical results.
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Intronic RNA FISH reveals deficient IL8 and CXCL2 biallelic
expression at the single-cell level
To provide orthogonal evidence for the mode of action suggested
by our i4C results and to obtain a single-cell-level understanding
of the enhancer-mutant effects, we performed RNA FISH with
probes targeting the intronic (nascent) RNA produced by the IL8
and CXCL2 loci alongside of either ACTB or IL8 mRNA (Fig 5A).
Since transcriptional events occur in bursts, this approach allows
quantification of transcriptional activity at individual transcription
sites (Bartman et al, 2016). Quantification and statistical compar-
ison of signals obtained in the presence/absence of IL-1a across
all enhancer-mutant lines showed that microdeletion markedly
reduces IL8 and CXCL2 transcription after 1 h of stimulation,
without apparent hierarchy. Cells carrying either both enhancer
deletions (Dp65eIL8+eCXCL2) or the full RELA knockout showed
essentially no IL8/CXCL2 activation (Fig 5B). We reasoned that
this lack of a hierarchical effect was due to allelic discrepancies
in IL8 and CXCL2 expression, as proinflammatory genes tend to
be stochastically activated (Paixao et al, 2007; Apostolou &
Thanos, 2008; Papantonis et al, 2010, 2012). Thus, we revisited
our RNA FISH data stratifying for the fraction of cells showing
colocalizing IL8 and CXCL2 intronic signals (i.e., transcribed from
the same allele) reasoning that these events represent maximal IL-
1a-induced enhancer activation. Colocalization was significantly
reduced in Dp65eIL8 cells and essentially eliminated in
Dp65eIL8+eCXCL2 cells, whereas the Dp65eCXCL2 mutant had only a
marginal effect on both biallelic expression and colocalization
(Fig 5C). All effects were suppressed in DRELA cells, in line with
p65 driving inducible transcription across the chemokine locus
(Fig 5C). Last, we performed intronic RNA FISH targeting IL8 and
CXCL2 in the presence/absence of TAKi in HeLa, as well as in
diploid retinal pigment epithelial (RPE-1) cells, verifying the tran-
scriptional inhibition of mono- and biallelic expression of both
loci (Fig 5D and E). This line of experiments supports the hierar-
chical relationship between the IL8 and CXCL2 enhancers also at
the single-cell and nascent gene transcription levels.
CRISPR-based activation of the IL8 promoter and enhancer
exerts discrete transcriptional effects
To validate our hierarchical model via an independent gain-of-func-
tion approach, we used the recently developed synergistic activation
mediator (SAM) system (Konermann et al, 2015). This allows
induction of single genes by specific targeting with an inactive Cas9
fused to the strong transactivation domains from NF-jB (p65) and
heat-shock factor 1 (HSF1) (Fig 6A). Targeting of this complex to
the IL8 promoter resulted in its multi-fold activation, but induced no
other gene in the entire locus (Fig 6B). However, targeting of the
IL8 enhancer using two different sgRNA pools activated not only
IL8, but also CXCL1 (while also mildly affecting CXCL2/3; Fig 6B).
Repeating this approach with sgRNAs targeting the CXCL2 enhancer
and/or promoter failed to activate any other genes besides CXCL2
(Fig 6B). These results are in full agreement with all previous data
suggesting the functional dominance of the IL8 “master” enhancer
in controlling genes in the extended chemokine locus.
A complex enhancer hierarchy in TNFa-stimulated primary
endothelial cells
To investigate whether a complex enhancer hierarchy also occurs in
response to other cytokines, we tested two well-studied TNFa-
responsive loci on chromosome 14 (Papantonis et al, 2012; Kolovos
et al, 2016) for changes in interactions in RELA-deficient HeLa cells.
Using the SAMD4A promoter as viewpoint in i4C experiments, we
confirmed previously published interactions in untreated and TNFa-
stimulated cells (Brant et al, 2016). The BMP4 promoter interacted
with the SAMD4A promoter in both unstimulated and TNFa-treated
cells (Appendix Fig S8B), despite the fact that they reside in two
consecutive TADs (Appendix Fig S6B); again, interactions were
largely p65-independent (Appendix Fig S8B). This prompted the
question of whether enhancer hierarchies like those described above
for the IL8/CXCL2 locus also apply to cytokine-responsive loci in
neighboring TADs.
To address this, we revisited i4C data from human primary
endothelial cells (HUVECs) in the presence/absence of TNFa stimu-
lation (Brant et al, 2016). Indeed, we could detect interactions
between the BMP4 and SAMD4A promoters irrespective of cytokine
treatment (Fig EV5A, top). We previously showed that the enhancer
upstream of BMP4 (eBMP4) exerts mostly repressive effects to the
gene, because it contains non-canonical NF-jB binding sites and
recruits the negative regulator JDP2 (Kolovos et al, 2016). On the
other hand, the enhancer cluster in the first SAMD4A intron assists
in gene activation (Larkin et al, 2012; Diermeier et al, 2014; Kolovos
et al, 2016). We generated i4C data from eBMP4 and from the most
TSS-proximal SAMD4A enhancer (eSAMD4A) after 60 min of TNFa
stimulation and observed that each enhancer contacts its cognate
gene promoter, but eSAMD4A also strongly contacts the BMP4
promoter (Fig EV5A, bottom). We then reasoned that deletion of
these enhancers would differentially affect the response of BMP4
and SAMD4A to TNFa, with the former being typically suppressed
and the latter markedly induced (Kolovos et al, 2016). Using
CRISPR/Cas9 deletions, we removed the whole eBMP4 or eSAMD4A
regions in > 30% and ~12% of alleles in a heterogeneous HUVEC
◀ Figure 4. Spatial chromatin interactions in the IL8 locus are rewired by deleting p65-binding cis-elements within enhancers.A i4C profiles in the 1 Mbp around the IL8 locus on chromosome 4 (ideogram) from control (empty vector) and enhancer-mutant (Dp65eIL8 and Dp65eCXCL2) HeLa lines
 IL-1a stimulation for 60 min, generated using the IL8 promoter (pink highlight) or enhancer (blue highlight) as a viewpoint. For the IL8 promoter, the average of two
biological replicates is shown, while for the IL8 enhancer, data from one replicate are shown. Below each profile, significantly strong (brown), medium (red), or weaker
interactions (orange) called via foursig are indicated. All profiles are shown aligned to gene models (blue) and to CTCF, H3K4me1, H3K4me3, H3K27ac, and RNA
polymerase II ENCODE HeLa-S3 ChIP-seq profiles. The breadth of TADs in the locus is indicated above.
B Meta-plots showing coverage of H3K27ac ChIP-seq signal at i4C fragments  1 kbp contacted by the IL8 promoter or enhancer in control cells (empty vector) in the
presence (magenta) or absence (gray) of IL-1a stimulation for 60 min, and in enhancer-mutant cells (Dp65eIL8, blue; Dp65eCXCL2, green) after IL-1a stimulation.
Source data are available online for this figure.
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population (as it is especially challenging to obtain single-cell-
derived pools; Fig EV5B and C). Despite not being present in all alle-
les, these deletions caused effects on both genes: Deleting eBMP4
leads to the partial derepression of BMP4, while also suppressing
SAMD4A (Fig EV5B). Deleting eSAMD4A negatively affects the
TNFa-mediated induction of SAMD4A, while also suppressing BMP4
expression (the TNFa-inducible CXCL2 gene provides a control;
Fig EV5C). Notably, the enhancer region in the deleted eBMP4 allele
A
C
D E
B
Figure 5.
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still interacts with the BMP4 promoter (Fig EV5A, bottom). Finally,
to further support this functional crosstalk, we adapted an approach
similar to the “multi-contact” 4C approach (MC-4C; Allahyar et al,
2018) on the basis of i4C and by coupling it to PacBio long-read
sequencing (Fig EV5D and E). We generated MC-i4C interactomes
for the SAMD4A promoter and enhancer, as well as for the BMP4
enhancer. They appear to contribute to a higher-order chromatin
hub, which would allow for the observed functional interference
and co-regulation (Fig EV5F). Thus, we obtained evidence from
diploid primary cells on the existence of complex enhancer hierar-
chies in response to cytokine stimulation, whereby two enhancers
separated by > 0.5 Mbp confer unequal regulation across a TAD
boundary in response to inflammatory stimuli.
Discussion
Genetic and structural variation at enhancers is increasingly
discussed as an underlying cause for disease, such that the term
“enhanceropathies” has now been coined (Chen et al, 2018;
Patten et al, 2018; Rickels & Shilatifard, 2018). While this concept
evolved from cancer studies, emerging evidence supports a role of
chromatin architecture and the non-coding genome also in
inflammatory responses and the immune system (Smale & Natoli,
2014; Smale et al, 2014). In this context, enhancers have been
shown to control differentiation and transcriptional responses in
innate immune cells. For example, lymphocytes from lupus
patients have altered histone quantitative trait loci (hQTLs) link-
ing quantitative changes in enhancer PTMs to the disease (Pelikan
et al, 2018). Likewise, enhancers of colon epithelial cells isolated
from patients with inflammatory bowel disease are enriched in
disease-linked SNPs (Boyd et al, 2018). Thus, understanding how
distinct enhancers may synergistically or antagonistically control
particular gene loci via detailed perturbations represents an
eminent biomedical goal.
To this end, we present here new data on how a hierarchical
regulatory relationship between two single cytokine-activated
enhancers controls the prototypic chemokine locus expressing
CXCL1-3 and IL8 (CXCL8) in human epithelial cells. The coordinated
and quantitative expression of these genes is of high
pathophysiological relevance, as the formation of chemokine gradi-
ents is an indispensable step for leukocyte recruitment to any
inflamed tissue, thus constituting a fundamental process of innate
immunity (Tan & Weninger, 2017). Chemokines are also key factors
of the inflammatory tumor microenvironment, in which IL-8 is
specifically known to also promote angiogenesis (Liu et al, 2016).
First, we use ATAC-seq to show increased and coordinated chro-
matin accessibility around NF-jB binding sites, in line with previous
nucleosome positioning data suggesting the immediate-early prim-
ing of the chromatin landscape for inflammatory stimulation (Dier-
meier et al, 2014). Accessible ATAC-seq footprints are also rich in
AP-1 motifs (FOS, FOSL1/L2, c-JUN/JUND/JUNB), on top of the
various NF-jB ones. We previously showed that these factors bind
to IL8/CXCL2 enhancers in an IL-1a/TAK1/p65-dependent manner
and that RELA (p65) knockdown prevented AP-1 loading and gene
activation. In contrast, knockdown of c-Fos or JunD only weakly
affected IL8 or CXCL2 expression and had no effect on p65 enhancer
binding (Jurida et al, 2015). Together, these data suggest that AP-1
coordinates with NF-jB for recruitment to chromatin and then plays
a role in IL-1a-mediated chromatin folding rather than in transcrip-
tion. Along these lines, such cooperativity has been shown for AP-1
contributing to static and dynamic chromatin looping in developing
macrophages (Phanstiel et al, 2017), for the NF-jB-assisted loading
of STAT3 at IL-1a-activated enhancers in hepatocytes (Goldstein
et al, 2017; Vierbuchen et al, 2017; Madrigal & Alasoo, 2018), as
well as for the role of AP-1 in chromatin accessibility and enhancer
selection in murine fibroblasts or iPSCs (Goldstein et al, 2017; Vier-
buchen et al, 2017; Madrigal & Alasoo, 2018).
Additional data from heterologous reporters and FAIRE now
support a direct role of p65 NF-jB in changing the nucleosomal
landscape at activated loci. This again may require cooperation
with preloaded AP-1 factors, as so far there is little evidence to
suggest that NF-jB alone acts as a pioneering factor (Diermeier
et al, 2014; Monticelli & Natoli, 2017). Importantly, our work
demonstrates how the TAK1 kinase may integrate all these
processes, as its pharmacological inhibition suppresses factor
recruitment, chromatin folding, and gene activation, most likely
due to the relevance of TAK1 for activation of NF-jB and also
MAPK signaling cascades that finally trigger activity of additional
TFs such as AP-1 (Jurida et al, 2015).
◀ Figure 5. Intronic RNA FISH reveals reduced concomitant biallelic and colocalizing chemokine expression in enhancer-mutant HeLa.A Representative triple RNA FISH images from HeLa cells  IL-1a stimulation for 60 min. Mature mRNAs (IL8, b-actin; red) and intronic RNAs (CXCL2, purple; IL8, green)
are detected against nuclei stained with Hoechst 33342 (blue). Typical foci marking individually labeled IL8/CXCL2 transcription sites or merged signals indicating co-
transcription and spatial proximity are enlarged (inset). Scale bar: 10 lm.
B Quantification of RNA FISH signals from parental (wt), control (vector), p65-deletion (Dp65eIL8 and Dp65eCXCL2), or p65-knockout (DRELA) HeLa lines  IL-1a
stimulation for 60 min. Negative controls (neg ctrl) indicate samples from IL-1a-stimulated control cells in which RNA FISH was performed using pre-amplifier,
amplifier, and label probe mixes, but omitting the specific probe sets for IL8 or CXCL2. These samples were used to define unspecific signals. Data from three
independent experiments are pooled and plotted. The box plots show the distributions of FISH signals. Boundaries of the box indicate the 25th/75th percentiles, black
lines mark medians, and colored lines mark means, respectively. Whiskers (error bars) indicate the 10th/90th percentiles, and circles mark all remaining outliers.
C The data from panel (B) were used to separately quantify the fraction of cells with mono- or biallelic IL8 or CXCL2 intronic RNA expression (purple, green, blue colors), as well
as the extent of colocalizing (overlapping) intronic RNA FISH signals in individual cells, indicating simultaneously activated transcription sites on the same allele (yellow
colors). The total numbers of cells analyzed are shown above each bar. Data are depicted relative to the total number of analyzed cells. *P < 0.05; Fisher’s exact test.
D Parental (wt) or control HeLa cells (vector) were treated with the TAK1 inhibitor (TAKi) or solvent (DMSO) for 30 min  IL-1a stimulation for 60 min. Intronic RNA
FISH was performed in three independent experiments and quantified as in panel (C). The total numbers of cells analyzed are shown above each bar. *P < 0.05;
Fisher’s exact test.
E As in panel (D), but for human pigmented retinal epithelial cells (RPE-1) treated with the TAK1 inhibitor (TAKi) or solvent only (DMSO) for 30 min  IL-1a stimulation
for 60 min.
Data information: In panels (D, E), data are pooled from three independent experiments.
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Remarkably, the perturbation of chemokine enhancers affected
the IL-1a response at multiple levels. In particular, the IL8
enhancer seems to exert a dominant function in this inflammatory
pathway. At this point, we can offer several explanations for this
effect. First, data from this study suggest that the enhancer regu-
lates rapid autocrine feedback loops involving the most abundant
A
B
Figure 6. Heterologous activation of the IL8 enhancer triggers IL8 and CXCL1 expression.
A A CRISPR activation (CRISPRa) strategy was applied to test enhancer functions individually. This approach involves a “dead” Cas9 (blue) and VP64 (green) fusion
protein that recruits the NF-jB (orange) and HSF1 (red) transactivation domains via MS2 recognition of two stem loops in the sgRNA scaffold (magenta). These
complexes were targeted to the IL8 or CXCL2 enhancers and promoters (highlights) via different sgRNA pools in HeLa. The position of individual sgRNAs used for
CRISPRa is shown in more detail in Fig EV1.
B Left bar graphs: Wild-type HeLa cells were transiently transfected with different combinations of plasmids encoding the “dead” Cas9-VP64 fusion protein, the MS2-
p65-HSF1 fusion protein, and empty sgRNA vector or versions containing sgRNAs targeting the IL8 enhancer or promoter. Twenty-four hours post-transfection, cells
were lysed and total RNA was analyzed for expression changes of the indicated genes compared to samples carrying dCas9-VP64 and MS2-p65-HSF1 fusions, but no
sgRNAs. Right bar graphs: The same experiments were performed using sgRNAs targeting the CXCL2 enhancer and promoter.
Data information: All data are from four independent transfections. Shown are mean values  SEM. P-values are derived from unpaired t-tests comparing every
condition against cells expressing all transactivators but lacking sgRNAs (first lane in each graph). Only significant differences are marked by asterisks.
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secreted factors IL-8, IL-6, and CCL20/MIP-3a, which are known to
support various inflammatory signaling pathways (Heinrich et al,
2003; Manna & Ramesh, 2005; Ha et al, 2017; Jin et al, 2018). It
has been shown that IL-8 activates nuclear translocation of NF-jB
in HeLa cells, which is consistent with the downregulation of NF-
jB signaling observed in the IL8 enhancer-mutant cells (Manna &
Ramesh, 2005). Second, it is possible that our enhancer mutations
indirectly affect the scaffolding function of a new class of long
non-coding (lnc)RNAs that connect enhancers with promoters in
cis through the WDR5-MLL1 protein complex within the CXCL
chemokine locus (Fanucchi et al, 2019). In the TNFa response,
these lncRNA–protein interactions apparently also activate tran-
scription of multiple immune genes, adding to the idea of an
upstream function of the chemokine locus in the inflammatory
response. However, that mechanism is disparate to the one
reported here, as it neither involves NF-jB components nor does it
change chromatin looping in the CXCL locus (Fanucchi et al,
2019). Third, based on the highly coordinated activation of IL-1a
target genes and their suppression upon enhancer perturbation, the
chemokine locus may rapidly extrude and loop out of its chromo-
some territory to contact other loci (IL6, CCL20, NFKBIA) in trans.
So far, we did not detect such contacts in our i4C data, but these
interactions may occur less frequently, more stochastically, and in
a burst-like fashion and, therefore, escaped detection. However,
the strong phenotypes described here can be surveyed in future
experiments to reveal the existence and functions of such inter-
chromosomal contacts by more sensitive, emerging methods
(Maass et al, 2019).
Once chromatin accessibility in response to IL-1a is ensured,
multiple spatial contacts were seen to form natively in the IL8/CXCL
locus, but these only weakly depend on chromatin binding by NF-
jB (which also holds true for the BMP4/SAMD4A loci). Notably, we
observe pre-established and persistent interaction between the IL8
and CXCL2 enhancers flanking the locus. Both these enhancers are
rapidly activated in response to IL-1a, but their detailed analysis
revealed that despite their identical activation patterns, the former
has a dominant effect for gene activation, whereas the latter essen-
tially only controls its nearby CXCL2 gene promoter. This is strictly
modulated by the “master” enhancer element, since neither heterol-
ogous activation nor CRISPR/Cas9 deletion of the IL8 promoter
affected any other gene in the locus.
Somewhat similar hierarchies were recently proposed for individ-
ual enhancers within the MYO1D and SMYD3 “super-enhancer”
clusters (Huang et al, 2018). Of course, these are multiple enhancers
controlling a single target gene, but they could be subdivided into
“hub” and “non-hub” enhancers on the basis of their CTCF/cohesin
association and disease-relevant SNP content to show that hub
enhancers are principal contributors to gene activation (Huang et al,
2018). Here, using primary endothelial cells and an i4C variant that
allows identification of multi-way contacts, we can propose a spatial
enhancer crosstalk taking place even across a TAD boundary and
allowing formation of a “factory” that permits complex regulatory
hierarchies to unfold.
In summary, the identification of hierarchically organized and
spatially co-associated signal-responsive enhancers highlights the
importance of chromatin-based mechanisms for inflammatory gene
responses and adds a perhaps unforeseen layer to their regulation in
cell nuclei.
Materials and Methods
Cell lines and cytokine treatments
HeLa cells (Handschick et al, 2014), KB cells (Jurida et al, 2015),
and hTERT-immortalized retinal pigment epithelial cells (hTERT
RPE-1, ATCC CRL-4000TM, a kind gift from Zuzana Storchova,
Martinsried, Germany) were maintained in Dulbecco’s modified
Eagle’s medium (DMEM) or DMEM high glucose (GlutaMAX supple-
mented with pyruvate) or DMEM/F12 (RPE-1), complemented with
10% fetal calf/bovine serum (FCS or FBS from PAN Biotech), 2 mM
L-glutamine (HeLa and KB cells), 100 U/ml penicillin, and 100 lg/ml
streptomycin. HeLa and KB cells were tested for mycoplasma with
VenorGeM Classic kit (Minerva Biolabs), and their identity was
confirmed by commercial STR testing at the DSMZ-German Collec-
tion of Microorganisms and Cell Cultures (https://www.dsmz.
de/dsmz). Stable pools of cell lines generated by transfections
of the pX459-based CRISPR/Cas9 constructs were selected and
maintained in puromycin (1 lg/ml). Prior to all experiments, puro-
mycin was omitted for 24 h and IL-1a (10 ng/ml) was added
directly to the cell culture medium. TAK1 inhibitor (5Z-7-
oxozeaenol) was always added 30 min prior to further treatments.
HUVECs from pooled donors (Lonza) were maintained in complete
Endopan-2 (PAN Biotech) supplemented with 3% FCS and serum-
starved in 0.5% FCS overnight before TNFa treatment (Peprotech;
10 ng/ml).
Cytokines, inhibitors, and antisera
Human recombinant IL-1a was a kind gift from Jeremy Saklatvala
(Oxford, UK) or was prepared in our laboratory as described and
used at 10 ng/ml final concentration in all experiments (Rzecz-
kowski et al, 2011). Human recombinant TNFa (used at 10 ng/ml
final) was from ImmunoTools. The following inhibitors were used:
actinomycin D (Sigma-Aldrich, #A1410), leupeptin hemisulfate
(Carl Roth, #CN33.2), microcystin (Enzo Life Sciences, #ALX-350-
012-M001), pepstatin A (Applichem, #A2205), PMSF (Sigma-
Aldrich, #P-7626), and 5Z-7-oxozeaenol (Tocris Bioscience,
#253863-19-3, or, Enzo Life Sciences, #66018-38-0). The inhibitors
actinomycin D (5 lg/ml final) and 5Z-7-oxozeaenol (1 lM final)
were dissolved in DMSO prior to use and applied at dilutions
> 1:1,000. Appropriate DMSO concentrations served as vehicle
controls in experiments using small-molecule inhibitors. Pepstatin
A, PMSF, and microcystin were dissolved in ethanol and leupeptin
as well as the protease inhibitor cocktail tablet in dH2O. Other
reagents were from Sigma-Aldrich or Thermo Fisher Scientific,
Santa Cruz Biotechnology, Jackson ImmunoResearch, or InvivoGen
and were of analytical grade or better. Primary antibodies against
the following proteins or peptides were used: anti-b-actin (Santa
Cruz, #sc-4778), anti-CRISPR-Cas9 (Abcam, #191468), anti-CTCF
(Millipore, #07-729), anti-FLAG (Sigma-Aldrich, #F1804), anti-H3
(Abcam, #ab1791), anti-H3K4me1 (Abcam, #ab8895), anti-H3K27ac
(Diagenode, Pab-174-050), anti-H3K27me3 (Millipore, #07-449),
anti-H3K36ac (Diagenode, #C15410307), anti-(PS32)-IjBa (Cell
Signaling, #2859), anti-IjBa (Cell Signaling, #9242), anti-P(T183/
Y185)-JNK (Cell Signaling, #9251), anti-JNK (Santa Cruz, #sc-571),
anti-P(S536)-p65 (Cell Signaling, #3033), anti-p65 (Santa Cruz, #sc-
372; #sc-8008), anti-P(T180/Y182)-p38 (Zymed, #36-8500), anti-
14 of 22 The EMBO Journal e101533 | 2019 ª 2019 The Authors
The EMBO Journal Sinah-Sophia Weiterer et al
p38 (Cell Signaling, #9212), anti-puromycin (3RH11; Kerafast,
#EQ0001), anti-P(S2)-RNA Pol II (Abcam, #ab5095), anti-P(S5)-Pol
II (Abcam, #ab5131), anti-RNA-Pol II (Millipore, #17-620), anti-
tubulin (Santa Cruz, #sc-8035), and normal rabbit IgG (Santa Cruz,
#sc-2027; Cell Signaling #2729). Secondary antibodies used for
immuno-FISH and immunoblotting were DyLight 488-coupled anti-
mouse IgG (ImmunoReagent, #DkxMu-003D488NHSX), goat anti-
rabbit IgG Cy3 (Diagenode, #111-165-003), HRP-coupled anti-
mouse IgG (Dako, #P0447), HRP-coupled anti-rabbit IgG (Dako,
#P0448; Thermo Fisher Scientific, #31460), and TrueBlot HRP-
conjugated anti-rabbit IgG (Rockland, #18-8816-31).
Plasmids and transient or stable transfections
The following plasmids were gifts or were obtained commercially:
pSpCas9(BB)-2A-Puro (pX459; Addgene (#48139)), pSpCas9(BB)-
2A-Puro V2.0 (pX459V2.0, Addgene (#62988)), lenti-sgRNA(MS2)-
zeo backbone (Addgene, #61427), lenti dCAS9-VP64_Blast
(Addgene, #61425), and lenti MS2-P65-HSF1_Hygro (Addgene,
#61426). The following vectors were cloned: pX459sg1Δp65, pX459-
sg1IL8Promoter, pX459-sg1/2/3IL8Enhancer, pX459-sg1/2CXCL2En-
hancer, pX459V2.0-sg2IL8Promoter, lenti-sgRNA(MS2)-zeo-sg1/2/
3/4IL8Promoter, lenti-sgRNA(MS2)-zeo-sg1/2/3/4/5/6/7/8IL8En-
hancer, lenti-sgRNA(MS2)-zeo-sg1/2/3/4/5CXCL2Promoter, and
lenti-sgRNA(MS2)-zeo-sg1/2/3CXCL2Enhancer. For mRNA expres-
sion analysis and immunoblotting experiments, HeLa cells were
seeded at 0.5 × 106 cells per 60-mm dish or 1.5 × 106 cells per 100-
mm dish. For single-cell analysis (RNA FISH), cells were seeded at
9,000 cells per slot in l-slides VI (Ibidi). For stable sgRNA transfec-
tions, HeLa cells were transfected by the calcium-phosphate method
and pools of cells were selected in complete medium with 1 lg/ml
puromycin (Kracht Lab). For CRISPR/Cas9-mediated knockout of
p65 in HeLa cells (Schmitz Lab; Appendix Fig S1), the non-trans-
fected cells were eliminated by the addition of puromycin (1 lg/ml)
1 day after transfection for 48 h. After approximately 1 week,
single-cell-derived clones were picked and further analyzed for
expression of p65 and FLAG-Cas9.
CRISPR/Cas9-mediated deletion of enhancer elements
and validations
In HeLa cells, the classical CRISPR-Cas9-system was used to specifi-
cally delete elements within enhancers. The sgRNA oligos (designed
with http://crispr.mit.edu/) were cloned into the pSpCas9(BB)-2A-
Puro (PX459) (#48139; V2 #62988) vector. This was done according
to the cloning strategy described in Ran et al (2013). For the genera-
tion of each enhancer deletion site, a flanking pair of sgRNA
constructs was synthesized as DNA oligonucleotides (Eurofins,
HPSF, no modifications). The top and bottom strands of sgRNA
encoding oligonucleotide (final concentration of 100 lM) were
annealed and phosphorylated by polynucleotide kinase (T4 PNK,
Thermo Fisher scientific, #EK0031) reaction. The double-stranded
and phosphorylated oligos were then diluted 1:8 and ligated into the
pX459 vector using the restriction enzyme BbsI (Bpil, 10 U/ll;
Thermo Fisher Scientific, #FD1014) and the T4 DNA ligase (5 U/ll;
Thermo Fisher Scientific, #EL0014). To digest any residual linear-
ized DNA, a digestion with Plasmid-Safe exonuclease (10 U/ll;
Biozym) was performed. Afterwards, the digested ligation reaction
was transformed into chemically competent E. coli bacteria.
Successful cloning was validated by Sanger sequencing using a
sequencing primer covering the RNU6 promoter region 235 bp 50 of
the BbsI site. Plasmids were transfected into the HeLa cells by the
calcium-phosphate method. One day after transfection, cells were
split 1:3 and puromycin (final concentration 1 lg/ml) was added to
the medium until stable cell lines were established. All experiments
were performed with pools of cells. The sequences of sgRNAs are
listed in Appendix Table S1. These stable CRISPR cell lines were
cultured in DMEM complete medium plus puromycin (1 lg/ml). To
validate the engineered mutations at DNA level, cell pellets were
recovered from 60-mm cell culture dishes and washed in PBS. Isola-
tion of genomic DNA was performed using the NucleoSpin Tissue
kit (Macherey-Nagel) according to the manufacturer’s instructions,
and the DNA was eluted in 80 ll of elution buffer. Afterwards, the
locus of interest was amplified by PCR using the GoTaq Flexi DNA
Polymerase (Promega) and the following PCR conditions: denatura-
tion at 95°C for 2 min, 35 cycles of 95°C for 30 s, 60°C for 30 s, and
72°C for 40 s, and final elongation at 72°C for 5 min. The correct
product size was analyzed on 1.5% agarose gels and the amplified
DNA was isolated using the NucleoSpin Gel and PCR Clean-up kit
(Macherey-Nagel) according to the manufacturer’s instructions. The
DNA was eluted in H2O. The isolated samples were prepared for
sequencing according to the LGC guidelines for DNA. All primer
pairs used for amplifying genomic DNA and sequencing are listed in
Appendix Table S1. For HUVECs, sgRNAs were designed with the
online CRISPR Design Tool (http://tools.genome-engineering.org) to
target ~1-kbp regions around two enhancers in BMP4 and SAMD4A.
sgRNAs upstream of each enhancer were cloned into pSpCas9(BB)-
2A-GFP (PX458) vector (Addgene plasmid #48138), while sgRNAs
downstream of the enhancers were cloned into pSpCas9(BB)-2A-
Puro (PX459) vector (Addgene, plasmid #48139). Human umbilical
vein endothelial cells (HUVECs) were transfected via electroporation
using 25 lg of each construct per 106 cells in OptiMEM (20 ms pulse
at 250 V in square waves on a Gene Pulser Xcell Electroporation
System; Bio-Rad). After puromycin selection (1 lg/ml) for 48 h,
cells were expanded for ~3 weeks. Genomic DNA was isolated and
used as template in PCR and qPCR in order to validate and quantify
the deletion. PCR products were sequenced to confirm the sequence
of the sub-population carrying the enhancer’s deletion.
CRISPR–dCas9 activation (CRISPRa)
We used the structure-guided engineered CRISPR–dCas9 complex
(Konermann et al, 2015) to mediate efficient transcriptional activa-
tion at endogenous genomic loci of IL8 and CXCL2. The sequence-
specific sgRNAs were designed following described guidelines, and
sequences were selected to minimize off-target effects based on
publicly available filtering tools (http://crispr.mit.edu/). The sgRNA
oligonucleotides (produced by Eurofins) were cloned into lenti-
sgRNA(MS2)-zeo backbone vector by Esp3I digestion. HeLa cells
(2.4 × 105 cells per 60-mm cell culture dish) were transfected by the
calcium-phosphate method with a 1:1:1 mass ratio of lenti-sgRNA
(MS2)-zeo sgRNA, lenti-dCAS9-VP64_Blast, and lenti-MS2-P65-
HSF1_Hygro vectors (total plasmid mass of 12 lg/dish). Culture
medium was changed 5 h after transfection. Twenty-four hours after
transfection, cells were harvested for mRNA expression analysis by
RT–qPCR.
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mRNA expression analysis by RT–qPCR
1 lg of total RNA was prepared by column purification (Macherey-
Nagel or Qiagen) and transcribed into cDNA using Moloney murine
leukemia virus reverse transcriptase (Thermo Fisher Scientific,
#EP0352; or RevertAid Reverse Transcriptase, #EP0441) in a total
volume of 20 or 10 ll. 2 or 1 ll of this reaction mixture was used to
amplify cDNAs using assays on demand (0.25 or 0.5 ll) (Applied
Biosystems/Thermo Fisher Scientific) for ACTB (Hs99999903_m1),
GUSB (Hs99999908_m1), IL6 (Hs00174131_m1), IL8 (Hs0017
4103_m1), NFKBIA (Hs00153283_m1), CXCL1 (Hs00236937_m1),
CXCL2 (Hs00236966_m1), CXCL3 (Hs00171061_m1), CCL20
(Hs00171125_m1), and RELA (p65) (Hs00153294_m1), as well as
TaqMan Fast Universal PCR Master Mix (Applied Biosystems/
Thermo Fisher Scientific). Alternatively, primer pairs were designed
and used with Fast SYBR Green PCR Master Mix (Applied Biosys-
tems/Thermo Fisher Scientific). All PCRs were performed as dupli-
cate reactions on an ABI 7500 real-time PCR instrument. The cycle
threshold value (ct) for each individual PCR product was calculated
by the instrument’s software, and the ct values obtained for
inflammatory/target mRNAs were normalized by subtracting the ct
values obtained for GUSB or ACTB. The resulting Dct values were
then used to calculate relative changes of mRNA expression as ratio
(R) of mRNA expression of stimulated/unstimulated cells according
to the following equation: 2((Dct stim.)-(Dct unst.)).
Cell lysis and immunoblotting
For whole-cell extracts, cells were lysed in Triton cell lysis buffer
(10 mM Tris pH 7.05, 30 mM NaPPi, 50 mM NaCl, 1% Triton X-
100, 2 mM Na3VO4, 50 mM NaF, 20 mM ß-glycerophosphate, and
freshly added 0.5 mM PMSF, 2.5 lg/ml leupeptin, 1.0 lg/ml
pepstatin, and 1 lM microcystin). Cell lysates or subcellular frac-
tions were resolved in 7–12.5% SDS–PAGE gels, and immunoblot-
ting was performed as described (Hoffmann et al, 2005). Separated
proteins were electrophoretically transferred to PVDF membranes
(Roth, Roti-PVDF 0.45 lm). After blocking with 5% dried milk in
Tris–HCl-buffered saline/0.05% Tween (TBST) for 1 h, membranes
were incubated for 12–24 h with primary antibodies, washed in
TBST, and incubated for 1–2 h with the peroxidase-coupled
secondary antibody. Proteins were detected by using enhanced
chemiluminescence (ECL) systems from Millipore or GE Healthcare.
Images were acquired and quantified using a Kodak Image Station
440 CF and the software Kodak 1D 3.6, or the ChemiDoc Touch
Imaging System (Bio-Rad) and the software Image Lab V5.2.1 (Bio-
Rad), or X-ray films and the software ImageJ.
Co-immunoprecipitation
HeLa vector and Dp65eIL8 cells were seeded in 145-mm cell culture
dishes (3.5 × 106 cells), stimulated with IL-1a (10 ng/ml) for 0.5
and 1 h, and lysed in Triton cell lysis buffer. 15 ll of TrueBlot
anti-rabbit IgG IP Beads (Rockland, # 00-8800-25) per sample was
equilibrated in lysis buffer before adding 900 ll lysis buffer and
1 lg of primary antibodies (anti-NF-jB p65 sc-372 or normal rabbit
IgG sc-2027). The samples were rotated for 2 h at 4°C and centri-
fuged at 2,500× g at 4°C for 1 min. The supernatant was removed
and the pelleted beads were washed with 500 ll lysis buffer before
adding 750 lg of the cell lysates in a total volume of 900 ll lysis
buffer. The samples were rotated for 2 h at 4°C, centrifuged at
2,500× g at 4°C for 1 min, and washed 3× with 900 ll lysis buffer
with 5-min rotation steps at 4°C in between. After the last wash,
the supernatant was aspirated and the beads were boiled in 60 ll
2× Roti-Load buffer (Carl Roth, #K929.1) for 10 min at 95°C. After
spinning at 10,000 × g for 3 min, the supernatant was collected
and 30 ll was loaded onto one SDS gel together with 50 lg of the
simultaneously prepared cell lysates. Proteins were detected by
immunoblotting using primary antibodies (anti-p65, anti-IjBa)
followed by TrueBlot HRP-conjugated anti-rabbit IgG (Rockland,
#18-8816-31).
Puromycinylation assay
Parental HeLa cells or CRISPR-Cas9-based mutants were seeded in
10-cm cell culture dishes (1.4 × 106 cells). On the next day, cells
were washed gently 4× with warm PBS and medium was replaced
by 4 ml FBS-free medium with or without IL-1a (10 ng/ml) for 8 h.
Thirty minutes prior to harvest, puromycin (10 lM) was added to
the medium, and the supernatant was harvested and centrifuged at
15,000× g at 4°C for 30 min. Proteins from 1 ml of supernatant were
precipitated by adding 1 ml of 11% TCA on ice for 45 min and
centrifuged at 15,000× g/4°C for 15 min. The invisible pellet was
washed with 1 ml of ice-cold 100% ethanol for 30 min at 4°C,
centrifuged at 15,000× g/4°C for 15 min, shortly dried, and boiled
in 50 ll 2× Roti-Load buffer. 10% of the samples were separated by
a 12.5% SDS gel, and proteins were detected by silver staining. The
remaining samples were analyzed by immunoblotting with an anti-
puromycin antibody (Kerafast, EQ0001).
Cytokine arrays
Human cytokine arrays were used for the analysis of secreted
cytokines in cell culture supernatants. Parental HeLa cells or
CRISPR-Cas9-based mutants were seeded in 60-mm cell culture
dishes (5 × 105 cells). The following day, medium was replaced by
3 ml of complete medium (including FBS) for 8 h with or without
IL-1a (10 ng/ml). Afterwards, the cell culture supernatant was
harvested, centrifuged at 15,000× g at 4°C for 5 min, and stored at
80°C. The RayBio C-Series Human Cytokine Antibody Array C5
(AAH-CYT-5-8) was performed with 1 ml of the thawed supernatant
according to the manufacturer’s instructions, including a sample
incubation overnight at 4°C. Images were acquired and quantified
using a ChemiDoc Touch Imaging System (Bio-Rad) and the soft-
ware Image Lab V5.2.1 (Bio-Rad). Signal intensities of equally sized
regions (defined by the volume of the largest spot) covering each
arrayed spot were acquired using the volume tool of Image Lab
V6.0.1 (Bio-Rad). The global background subtraction tool was used
to obtain adjusted volume intensities (adjVI). These raw data are
plotted in Appendix Fig S3 and were used for further calculations.
Normalization was performed between two pairs of arrays (compar-
ing untreated/IL-1a-treated) separately for vector controls and
Dp65eIL8 and DRELA cell lines. Mean signals from six positive
controls (i.e., biotinylated antibody spots) of arrays performed with
samples from untreated conditions (the reference array) were
divided by the mean signals from positive controls of the IL-1a-
treated samples to obtain the normalization factor (n). Fold changes
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were calculated as follows: adjVI(IL-1a)*(n)/adjVI(untreated). The
mean signals of all negative controls (no antibody spots) were used
to define the threshold of detection.
ELISA
Sandwich ELISAs from R&D Systems (DuoSet ELISA human IL-8
(DY208) and IL-6 (DY206)) were used to measure secreted human
IL-8 or IL-6 protein concentrations in cell culture supernatants from
parental HeLa cells or mutant cell lines. The cells were seeded in 60-
mm cell culture dishes (5 × 105 cells), and at the next day the
medium (3 ml) of all samples was exchanged. Then, cells were left
untreated or were stimulated with IL-1a (10 ng/ml) for 3, 8, or 16 h
in complete medium (including FBS). Thereafter, the cell culture
supernatant was harvested, centrifuged at 15,000× g at 4°C for 15 s,
and stored at 80°C. The samples were diluted in cell culture
medium 1:5 (IL-8) or 1:20 (IL-6) and the ELISAs were performed
according to the manufacturer’s instructions using serial dilutions of
recombinant IL-8 and IL-6 as standards. All samples were within the
linear range of the standard curve. The obtained concentrations
were normalized for cell number on the basis of total RNA concen-
trations obtained from the corresponding cell pellets.
Immuno-RNA-fluorescence in situ hybridization (immuno-
RNA FISH)
For detection of specific transcripts, the Affymetrix FISH kit
QuantiGene ViewRNA ISH Cell Assay (Life Technologies GmbH,
QVC0001) was used in combination with specific branched-probe
sets against IL8 (VA4-13193, VA1-13103), NFKBIA (VA6-17971),
IL8-intronic (VA1-6000437), CXCL2-intronic (VA6-6000438), and
ACTB (VA4-10293) according to the manufacturer’s instructions.
For some experiments, this technique was further combined with
classical indirect immunofluorescence. A total of 9,000 cells were
seeded for 24 h in l-slides VI (Ibidi) and washed twice with 1× PBS
for 3 min. Subsequently, after fixation with 4% (w/v) paraformalde-
hyde in PBS (Santa Cruz, #281692) at 4°C overnight, cells were
washed three times with 1× PBS for 3 min, permeabilized with the
kit included detergent solution or PBS–Tween (1:1,000) at room
temperature for 5 min and washed twice with 1× PBS for 3 min. For
hybridization, probe sets (diluted 1:100) were incubated at 40°C for
3 h. The detection of labeled mRNAs was achieved using pre-ampli-
fier mix, amplifier mix, and label probe mix (diluted 1:30, respec-
tively), each incubated at 40°C for 30 min. Cells were washed twice
for 2 min and once for 10 min with wash buffer. For combination
with indirect immunofluorescence, the cells were washed for 1 min
twice with 0.1% (w/v) saponin/Hanks’ BSS (PAN, #P04-32505) and
subsequently blocked with 10% (v/v) normal donkey serum in
0.1% (w/v) saponin/Hanks’ BSS for 30 min. Protein detections
were enabled by incubation with specific primary (anti-p65 F-6
mouse antibody, Santa Cruz, 8008) and secondary antibodies, incu-
bated in 0.1% (w/v) saponin/Hanks’ BSS at 37°C for 1 h. DyLight
488-conjugated secondary antibodies (ImmunoReagent, DkxMu-
003-D488NHSX) were diluted 1:100. Cells were washed three times
for 10 min with 0.1% (w/v) saponin/Hanks’ BSS or Hanks’ BSS,
respectively. As control, the primary antibody was omitted. Nuclei
were stained with Hoechst 33342 (Invitrogen), and cells were finally
embedded in 30% (v/v) glycerol/Hanks’ BSS or Fluoromount-G
mounting medium (Thermo Fisher Scientific, #00-4958-02). For
control of unspecific FISH signals, a “no FISH probe” Control (Ctl)
was used for each experiment. This control excludes the FISH probe
sets and includes pre-amplifier, amplifier, and label probes. In case
of any unspecific signals, this control was used to determine the
processing settings for the entire experiment. Fluorescence analyses
were performed using the inverted microscope DMi8 (Leica) and the
Leica LASX software (version 1.5.1.13187). Quantification of mRNA
transcripts was performed using the Duolink Image Tool (version
1.0.1.2) from Olink Bioscience with the following settings for the
signal channel red: nuclei size (px): 68; cytoplasm size (px): 100,
signal threshold: 50–150, and signal size (px): 3–5.
3D-DNA FISH
3D-DNA FISH was performed using an adapted protocol based on
Bolland et al (2013). Differentially labeled commercial DNA probes
were obtained from Empire Genomics. Two large DNA probes mark
IL8 (IL8-20-RE, chr.4q13.3, 160 kb) and IL6 (IL6-20-GR, chr.7p15.3,
194 kb) loci. Additionally, chromosome 4 control probes (CHR04-
10-OR) were used, which bind to Chr.4p11 or Chr.4p13, respec-
tively. A total of 9,000 (HeLa, Dp65eIL8) to 12,000 cells (KB) were
seeded for 24 h in l-slides VI (Ibidi) and washed twice with PBS.
Cells were fixed for 10 min at room temperature by using 4% (w/v)
paraformaldehyde in PBS (Santa Cruz, #281692) and subsequently
quenched with 0.1 M Tris–HCl (pH 7.4) for 10 min at room temper-
ature. For permeabilization, cells were treated with 0.1% (w/v)
saponin/0.1% Triton X-100/PBS for 10 min at room temperature,
washed two times with PBS for 5 min, and incubated in 40% (v/v)
glycerol in PBS for 3 h followed by 3 freeze-thaw cycles in liquid
nitrogen. After thawing, cells were washed twice in PBS for 5 min,
incubated in 0.1 M HCl for 30 min, washed with PBS for 5 min,
permeabilized with 0.5% (w/v/v) saponin/0.5% Triton X-100/PBS
for 30 min, washed again with PBS for 5 min, and pretreated with
50% (v/v) formamide/2× saline–sodium citrate (SSC), pH 7.0, for at
least 30 min at room temperature. The hybridization mix contained
1.5 ll of each probe and 15 ll hybridization buffer (Empire
Genomic) and was filled up to 50 ll with 50% (v/v/w) formamide/
2× SSC/10% dextran sulfate (Sigma, #67578). Cellular DNA and
probes were separately denatured at 75°C for 5 min. Probes were
subsequently incubated on ice for 2 min and then prehybridized at
37°C for 10 min. Hybridization took place at 37°C in a humid cham-
ber overnight. Samples were washed briefly with 2× SSC and then
subjected to the following washing steps: 50% formamide/2× SSC
for 15 min at 45°C, 1× SSC for 15 min at 63°C, 2× SSC for 5 min at
45°C, 2× SSC for 5 min, and PBS for 5 min at room temperature.
Nuclei were stained with Hoechst 33342 (Invitrogen, 1 lM) for
5 min, and cells were finally embedded in 30% (w/v) glycerol/PBS.
Fluorescence microscopy was performed using the inverted Leica
DMi8 microscope and the Leica LASX software (version
1.5.1.13187). Z-stack images (in layers of 0.508 lm) were processed
by 3D deconvolution, contrast changes, and background elimina-
tion.
Immunofluorescence of LacO-array cells
Twenty-four hours prior to the experiment, cells were seeded on
coverslips on 12-well plates. After treatment required for the specific
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experiments, cells were washed twice with ice-cold PBS and fixed
with 4% paraformaldehyde for 10 min at room temperature. After
five washes with PBS, two of them for 5 min on a shaker, cells were
permeabilized with 0.15% Triton/PBS for 15 min. Prior to first anti-
body incubation overnight at 4°C with gentle rocking, cells were
blocked for 60 min at room temperature with 2% BSA in PBS with
0,05% Tween. The first antibody was prepared in the same solution.
Afterward, cells were washed three times for 5 min with PBS in a
shaker and the secondary antibody was added in the same solution
as the first antibody and incubated for 2 h with gentle shaking. Cells
were again rinsed briefly with PBS two times and washed three
times for 5 min with PBS on a shaker. For staining of nuclei,
Hoechst 33342 (1 lM in PBS) was added for 4 min, followed by two
brief rinses with PBS and two washes with PBS for 5 min in a
shaker. Cell-covered coverslips were then mounted on microscope
slides using gelatin. Immunofluorescence images were acquired at
room temperature with an Eclipse TE2000-E inverted microscope
(Nikon) equipped with an X-Cite Series 120 fluorescence microscope
light source (EXFO), a T-RCP remote control (Nikon), an ORCA-
spark Digital CMOS camera C11440-36U (Hamamatsu), and a Nikon
Plan Apo 100×/1.4 NA oil lens using NIS Elements AR 3.00 software
(Nikon).
Chromatin immunoprecipitation (ChIP) and data analysis
Two 140-mm cell culture dishes were seeded with 3.7 × 107 HeLa
cells, treated as described in the figure legends, and used for each
condition. Proteins bound to DNA were cross-linked in vivo with
1% formaldehyde added directly to the medium. After 10 min of
incubation at room temperature, 0.1 M glycine was added for 5 min
to stop the cross-linking. Then, cells were collected by scraping and
centrifugation at 1,610× g (5 min, 4°C), washed in cold PBS contain-
ing 1 mM PMSF, and centrifuged again at 1,610× g (5 min, 4°C).
Cells were lysed for 10 min on ice in 3 ml ChIP lysis buffer (1%
SDS, 10 mM EDTA, 50 mM Tris pH 8.1, 1 mM PMSF, Roche
protease inhibitor mix). The DNA was sheared by sonication
(28 × 30 s on/30 s off, power high; Bioruptor; Diagenode) at 4°C
and lysates cleared by centrifugation at 16,100× g at 4°C for 15 min.
Supernatants were collected and stored in aliquots at 80°C for
subsequent ChIP. For determination of DNA concentration, 20 ll of
sheared lysate was diluted with 100 ll TE buffer including 10 lg/ml
RNase A. After 30 min at 37°C, 3.8 ll proteinase K (20 mg/ml) and
1% SDS were added and incubated for at least 2 h at 37°C followed
by overnight incubation at 65°C. Samples were resuspended in two
volumes of buffer NTB (Macherey-Nagel) and DNA was purified
using NucleoSpin columns (Macherey-Nagel) according to the
manufacturer’s instructions. DNA was eluted with 50 ll 5 mM Tris
pH 8.5, and concentration was determined by NanoDrop. For CHIP,
the following antibodies were used: anti-histone H3 (2 lg; Abcam;
ab1791), anti-NF-jB p65 (3 lg; Santa Cruz; sc-372), anti-phospho-
Pol II (S5) (1.35 lg; Abcam; ab5131), H3K27ac (2 lg; Diagenode,
pAb-174-050), H3K4me1 (2 lg; Abcam, ab8895), IgG (2 lg; Cell
Signaling; 2729), and CTCF (4 ll; Millipore, 07-729). Antibodies
were added to precleared lysate volumes equivalent to 25 lg of
chromatin. Then, 900 ll of ChIP dilution buffer (0.01% SDS, 1.1%
Triton X-100, 1.2 mM EDTA, 167 mM NaCl, 16.7 mM Tris–HCl
pH 8.1) was added and the samples were rotated at 4°C
overnight. Thereafter, 30 ll of a protein A/G-Sepharose mixture,
pre-equilibrated in ChIP dilution buffer, was added to the lysates
and incubation continued for 2 h at 4°C. Beads were collected by
centrifugation and washed once in 900 ll ChIP low-salt buffer
(0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris pH 8.1,
150 mM NaCl), once in 900 ll ChIP high-salt buffer (0.1% SDS, 1%
Triton X-100, 2 mM EDTA, 20 mM Tris pH 8.1, 500 mM NaCl),
once in 900 ll ChIP LiCl buffer (0.25 M LiCl, 1% NP-40, 1%
desoxycholate, 1 mM EDTA, 10 mM Tris pH 8.1), and twice in
900 ll ChIP TE buffer (10 mM Tris pH 8.1, 1 mM EDTA) for 5 min
at 4°C. Beads were finally resuspended in 100 ll TE buffer including
RNase A (10 mg/ml). In parallel, 1/10 volume (2.5 lg) of the initial
lysate (input samples) was diluted with 100 ll TE buffer including
10 lg/ml RNase A. After 30 min at 37°C, 3.8 ll proteinase K
(20 mg/ml) and 1% SDS were added and both input and immuno-
precipitates were incubated for at least 2 h at 37°C followed by over-
night incubation at 65°C. Samples were resuspended in two
volumes of buffer NTB (Macherey-Nagel) and DNA purified using
NucleoSpin columns (Macherey-Nagel) according to the manufac-
turer’s instructions. DNA was eluted with 50 ll 5 mM Tris pH 8.5
and stored at 20°C until further use. PCR products derived from
ChIP were quantified by real-time PCR using the Fast ABI 7500
instrument (Applied Biosystems). The reaction mixture contained
2 ll of ChIP or input DNA (diluted 1:10 to represent 1% of input
DNA), 0.25 lM of primers, and 10 ll of Fast SYBR Green Master
Mix (2×) (Applied Biosystems) in a total volume of 20 ll. PCR
cycles were as follows: 95°C (20 s) and 40× (95°C (3 s), 60°C
(30 s)). Melting curve analysis revealed a single PCR product.
Calculation of enrichment by immunoprecipitation relative to the
signals obtained for 1% input DNA was performed. DNA isolated by
CTCF-CHIP was subjected to NGS as described (Jurida et al, 2015).
H3K27ac, H4K4me1, and p65 ChIP-seq data were analyzed as
described previously (Jurida et al, 2015). Coverage vectors and peak
sets from these data sets were visualized using R/Bioconductor
package (Hahne & Ivanek, 2016). Quantitative comparison of bind-
ing signals was done by extracting read counts across all enhancer
intervals and subsequent normalization of counts and detection of
differentially bound regions by DESeq2 (Love et al, 2014). Normal-
ized counts were plotted as bar plots for enhancer marked by signifi-
cant de-regulation of H3K27ac binding signals within CXCL2 and
CXCL8 regions, respectively.
ATAC-seq and data analysis
ATAC-seq was performed following a published protocol (Buen-
rostro et al, 2013). A total of 130,000 KB cells (untreated or treated
with IL-1a for 1 h, 5Z-7-oxozeaenol (for 30 min) or combinations
thereof) were harvested using trypsinization and washed with cold
PBS. Cells were centrifuged in 50 ll cold PBS (500× g, 5 min, 4°C),
and the supernatant was discarded. The cell pellet was resuspended
in 50 ll cold lysis buffer (10 mM Tris–HCl pH 7.5, 10 mM NaCl,
3 mM MgCl2, 0.1% IGEPAL CA-630), and the supernatant was
discarded after another centrifugation step (500× g, 10 min, 4°C).
The components for the transposase mix were part of the Illumina
Nextera DNA library preparation commercial kit, and each cell
pellet was incubated in 50 ll transposase mix (25 ll TD reaction
buffer, 2.5 ll TDE1 Tn5 transposase, 22.5 ll nuclease-free water) at
37°C for 30 min (gentle shaking). The samples were then purified
using the Qiagen MinElute PCR Purification commercial kit and
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eluted in 10 ll elution buffer (10 mM Tris–HCl pH 8). For library
preamplification, the purified 10-ll samples were amplified in ther-
mocycler using 25 ll NEBNext High-Fidelity PCR Master Mix, 10 ll
nuclease-free water, 2.5 ll Custom Nextera Primer 1 and 2 (25 lM),
and the following program: 1 cycle of 72°C for 5 min and 98°C for
30 s, and 5 cycles of 98°C for 10 s, 63°C for 30 s, and 72°C for
1 min. 5 ll of this PCR mixed with 4.41 ll nuclease-free water,
0.25 ll Custom Nextera Primer 1 and 2 (25 lM), 0.09 ll 100× SYBR
Green I, and 5 ll NEBNext High-Fidelity PCR Master Mix was used
to determine the final amplification steps with real-time PCR (1
cycle of 98°C for 30 s, and 20 cycles of 98°C for 10 s, 63°C for 30 s,
and 72°C for 1 min). Final library amplification was performed in
the thermocycler with the remaining 45 ll library PCR mix with an
additional cycle number calculated from real-time PCR cycle reach-
ing 1/3 of the maximum fluorescence signal (see described program
above for thermocycler). The amplified ATACSeq libraries were
purified using the Qiagen MinElute PCR purification commercial kit
and eluted in 20 ll elution buffer (10 mM Tris–HCl pH 8.0). Control
of the libraries before sequencing was done by Agilent Bioanalyzer
and additional test libraries separated with agarose gel electrophore-
sis (1% gel, 100 mV, 40 min). Following high-throughput sequenc-
ing on an Illumina platform, raw reads were mapped to the human
genome (reference build hg19) using default BWA (default settings;
Li & Durbin, 2010). Then, significant peaks (q-value < 104 and > 2
fold enrichment over background) from each condition were
selected and their genomic positions were used for further categori-
cal analysis. The positions of peaks were intersected with H3K27ac
ChIP-seq peaks (from Jurida et al, 2015), or raw ATAC-seq coverage
of genomic regions from the different conditions was subjected to
virtual footprinting for motif analysis by adapting the HINT subrou-
tine of the Regulatory Genomics Toolbox suite (http://www.regu
latory-genomics.org/). Coverage plots were generated using ngs.plot
(Shen et al, 2014), while all other heatmaps were prepared using
custom Python and R scripts (available on request).
FAIRE assay
This assay was performed essentially as described (Rodriguez-Gil
et al, 2018). A total of 1 × 107 cells were seeded in a T175 flask
24 h prior to the experiment. Subsequently, one flask was used per
condition. The next day, cells were stimulated as required and
cross-linked with formaldehyde (1% final concentration) for
10 min, followed by addition of glycine (100 mM final concentra-
tion) for 5 min. Cells were collected in the medium using a cell
scraper and immediately put on ice. After centrifugation for 5 min
at 4°C and 1,600 × g, the supernatant was aspirated and the pellet
was resuspended in 2 ml ice-cold PBS with PMSF (0.5 mM final
concentration) and again centrifuged. This step was repeated once.
After final washes, the pellet was resuspended in 1 ml of ChIP lysis
buffer (1% SDS, 10 mM EDTA, 50 mM Tris–HCl (pH 8.1); freshly
added: 1 mM PMSF, 10 mM NaF, 0.5 mM sodium orthovanadate,
10 lg/ml leupeptin, 10 lg/ml aprotinin) and lysed for 10 min on
ice. Sonication was carried out using a S220 Focused-ultrasonicator
(Covaris) with 1-ml AFA tubes. Settings were as follows: peak:
150W; duty factor: 15; cycles per burst: 500 (during pause: 2.5W);
and repetitions: 20. Sonicated lysates were then centrifuged at
16,100 × g for 15 min at 4°C and supernatants transferred to new
reaction tubes. 50 ll of the lysates was kept at 4°C as cross-linked
sample. Another 50-ll aliquot of the same lysate was de-cross-
linked as reference total DNA sample. For this purpose, 5 ll of
RNase A (final concentration: 1 lg/ll) was added and sample was
incubated for 30 min at 37°C. Next, 5 ll of proteinase K (final
concentration: 2 lg/ll) was added and sample was incubated for
4 h at 37°C, then for 6 h at 65°C. For purification of DNA, the cross-
linked as well as the de-cross-linked samples were diluted to 500 ll
with ddH2O. 500 ll of a phenol:chloroform:isoamyl alcohol mixture
was added, and samples were vortexed before centrifugation at
15,800 × g for 10 min at 4°C. 450 ll of the aqueous upper part was
transferred to a new reaction tube. After addition of 50 ll of NaCl
(final concentration: 125 mM) and 450 ll of isopropanol, samples
were mixed by inversion and incubated for 10 min at room temper-
ature. After centrifugation at 15,800 × g for 10 min at 4°C, the
supernatant was discarded and the pellet was washed with 200 ll of
cold (4°C) 70% EtOH. The supernatant was again discarded and
DNA pellets were left to air-dry before resuspension in 100 ll H2O.
For qPCR, 2 ll of the DNA was used per well as template. The de-
cross-linked sample and the ACTB-TSS primer pair were used as
reference to calculate the fold enrichment using the DDCT method
with the following formula: 2DDCT = ((CT gene of interest - CT
control gene) cross-linked sample)-((CT gene of interest - CT control
gene) de-cross-linked sample).
Microarray transcriptomics and data analysis
The “Whole Human Genome Microarray 4x44K v2” (Agilent-
026652, Agilent Technologies) covering the entire human transcrip-
tome was used in this study. cRNA was transcribed from total RNA
with the “Quick Amp Labeling kit, one-color” (#5190-0442; Agilent
Technologies). cRNA synthesis, cRNA fragmentation, hybridization,
and washing were carried out as recommended in the “One-Color
Microarray-Based Gene Expression Analysis (Quick Amp Labeling)”
guide (Agilent Technologies, G4140-90040 v5.7). Slides were
scanned on an upgraded Agilent Microarray Scanner G2565 CA with
a pixel resolution of 5 lm and a bit depth of 20. Data extraction was
performed with the “Feature Extraction Software” V10.7.3.1 by
using the default extraction protocol files “GE1_107_Sep09.xml”.
Extracted data were imported as single-color experiments into
GeneSpring GX V12.0 software (Agilent Technologies Inc., Santa
Clara, CA). Data were log2-transformed and quantile-normalized in
GeneSpring GX. Low anti-log-transformed values were raised to 13,
which was the mean value of all probes that were flagged by
“Feature Extraction Software” as “not detected”. In case of multiple
Agilent probes for the same gene, the probe having the highest
mean intensity was selected. A total of 21,765 probes on the array
were assigned to an EntrezGeneID. Thereof, 14,204 genes were
determined as expressed if they had an overall mean of at least 50
anti-log-transformed fluorescence units and were detected in at least
50% of the samples (“Feature Extraction Software” flag “detected”).
In order to analyze the effect of IL-1a in vector controls, differen-
tially expressed genes were identified using the moderated t-test of
GeneSpring GX V12.0 software against the untreated vector controls.
Ratio values with a P-value < 0.05 and > 3-fold changes were
considered as significant changes. Differentially expressed genes in
the three enhancer-deletion lines (Dp65eIL8, Dp65eCXCL2, and
Dp65eIL8+eCXCL2) were calculated similarly compared to the
untreated samples of each mutant using the moderated t-test
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(ratio > 3-fold, P < 0.05). Overrepresentation analyses were
performed on the web service Metascape (http://www.metascape.
org, Zhou et al, 2019). Pathway & process enrichment was done
against the 14,204 expressed genes as background set with the
following settings: Min Overlap: 3, P-Value Cutoff: 0.01, Min Enrich-
ment: 1.5, and selected sets: GO Molecular Functions, KEGG Func-
tional Sets, GO Biological Processes, and KEGG Pathway.
Intrinsic circular chromosome conformation capture (i4C),
MC-i4C, and data analyses
i4C was performed on ~5 million wild-type or CRISPR-modified KB
cells, HeLa cells, or HUVECs in two biological replicates (unless stated
otherwise). Preparation of i4C templates, using ApoI as the primary
restriction enzyme and the promoter/enhancer regions of IL8 and
CXCL2 as viewpoints, was performed exactly as described by Brant
et al (2016), while PCR-based generation of i4C libraries for sequenc-
ing on a HiSeq 2500 platform (Illumina) was as previously described
(Stadhouders et al, 2013) using the primers listed in the Key Resources
Table. Following sequencing to ≥ 8 million reads, analysis was
performed using the foursig algorithm (Williams et al, 2014) to obtain
a catalogue of significant cis-interactions for each replicate and view-
point; significant interactions shared by independent replicates (where
applicable) are presented under each i4C signal track. From the same
data, all trans-interactions were examined and intersected manually.
For the multi-contact (MC) i4C data from HUVECs, we generated i4C
libraries exactly the same way, PCR-amplified by the primers listed in
Appendix Table S1, and subjected to long-read sequencing on a
PacBio platform (via BaseClear, NL). Data analysis was performed as
described in Allahyar et al (2018) starting from CCS reads (to which
raw data were converted, provided directly by BaseClear), and all
interaction data were finally presented after assigning to non-overlap-
ping 10-kbp bins along chromosome 14 and visualized using custom R
scripts (available upon request).
Quantification and statistical analysis
Bands detected by immunoblotting were quantified using ImageJ
(http://rsbweb.nih.gov/ij/) or Bio-Rad Image Lab, version 5.2.1
build 11. Statistics (Mann–Whitney rank-sum test, t-tests, Fisher’s
exact test) were calculated using SigmaPlot 11, GraphPad Prism 6.0,
or Microsoft Excel 2013, or online at https://www.graphpad.com/
quickcalcs. Unless stated otherwise, in all box plots the boundary of
the box closest to zero indicates the 25th percentile, a black line
within the box marks the median, a red line marks the mean, and
the boundary of the box farthest from zero indicates the 75th percen-
tile. Whiskers (error bars) above and below the box indicate the
90th and 10th percentiles. Points mark the remaining outliers.
Data availability
The following published NGS data sets were used. For KB cells,
microarray, RNA-seq, and ChIP-seq data are available via our previ-
ous NCBI GEO submissions with the accession numbers GSE64224
and GSE52470 (https://www.ncbi.nlm.nih.gov/geo) (Jurida et al,
2015). For HeLa-S3 cells and HUVECs, all ChIP-seq data are from
the ENCODE project (www.encodeproject.org). New ATAC-seq,
CTCF ChIP-seq, and microarray data generated here are available
via the NCBI GEO repository under the accession number
GSE134436 (https://www.ncbi.nlm.nih.gov/geo), and all i4C data
are available via the SRA repository under the accession number
PRJNA552438 (https://www.ncbi.nlm.nih.gov/bioproject).
Bed files, bed graph files, and scripts for all i4C data are available
as compressed source data for Expanded View and Appendix figures.
Other resources
A detailed list of reagents, antibodies, and oligonucleotide
sequences used in this study is provided in Appendix Table S1.
Expanded View for this article is available online.
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